ArticleJournal of applied clinical medical physics2025
Combined application of block and modulation factors to reduce the volume of the low dose area in helical tomotherapy plans for lung cancer.
Article in Journal of applied clinical medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Combined application of block and modulation factors to reduce the volume of the low dose area in helical tomotherapy plans for lung cancer.Journal of applied clinical medical physics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe helical tomotherapy (HT) system can expose more normal lung tissue to low radiation doses, resulting in extensive low-dose distribution in both lungs which may induce radiation pneumonitis (RP). PURPOSE: This study aims to optimize dosimetric parameters and identify a clinically feasible treatment plan by analyzing the impact of different block settings and modulation factor (MF) combinations on HT plans for lung cancer to reduce the low-dose exposure volumes in normal lung tissue.
methodsWe retrospectively reviewed 14 lung cancer patients who received radiotherapy. These cases were optimized using different modulation factors (MFs: 3, 4, 5) and block techniques (Unblocked, Directional, Complete). The impact of MF and block combinations on reducing low-dose bath (e.g., V5, V10) in lung tissue was evaluated by analyzing dose distribution maps, dose-volume histograms (DVH), homogeneity index (HI), conformity index (CI), and treatment time for each optimized HT plan combination.
resultsBlock settings and higher MF exerted minimal influence on the average dose to the target volume. With stricter block constraints and higher MF, HI increased (range: 17.39%-27.54%) and CI decreased (range: 2.76%-17.43%); although both indices showed slight deterioration, they remained within acceptable clinical limits. Treatment time increased substantially (range: 15.77%-131.58%). The block technique significantly reduced V5 in the bilateral lungs and the contralateral (healthy) lung, with less impact on the ipsilateral (affected) lung. The combination of block and high MF effectively reduced V5.
conclusionsTo balance target volume coverage (high dose), dose distribution uniformity, and treatment duration while reducing low-dose irradiation to normal lung tissue, we recommend implementing Directional block with an MF range of 3-4 to optimize the HT plan for patients with unilateral lung cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.